GW-3965 hydrochloride, also known as GW3965 and CAS number 405911-17-3, is a potent and selective agonist of the liver X receptor (LXR). This product has gained attention in recent years due to its potential therapeutic benefits in the treatment of various metabolic disorders such as dyslipidemia, atherosclerosis, and type 2 diabetes.
Introduce this product: GW-3965 hydrochloride is a chemical compound that has been developed as a synthetic agonist for liver X receptors. It works by activating these receptors, which regulate the expression of genes involved in lipid metabolism. As a result, it can help improve cholesterol metabolism, reduce inflammation, and prevent the development of metabolic disorders.
Chemical name: The chemical name of GW-3965 hydrochloride is 2-(3-(3-(4-((2-chlorophenyl)methyl)phenoxy)propylthio)-1,2,4-triazol-5-ylthio)acetic acid hydrochloride.
Molecular formula: The molecular formula of GW-3965 hydrochloride is C25H24ClN5O3S2 • HCl.
Formula weight: The formula weight of GW-3965 hydrochloride is 610.47 g/mol.
CAS No: The CAS number of GW-3965 hydrochloride is 405911-17-3.
Top ten keywords from Google and Synonyms:
Synonyms for GW-3965 hydrochloride include 2-(3-(3-(4-((2-chlorophenyl)methyl)phenoxy)propylthio)-1,2,4-triazol-5-ylthio)acetic acid hydrochloride, GW-3965, and 405911-17-3.
Health benefits of this product: GW-3965 hydrochloride has the potential to provide numerous health benefits in the treatment of various metabolic disorders. As a liver X receptor agonist, it can help improve cholesterol metabolism, reduce inflammation, and prevent the development of dyslipidemia, atherosclerosis, and type 2 diabetes. Additionally, studies have shown that GW-3965 hydrochloride may be effective in treating other conditions such as Alzheimer's disease, cancer, and inflammatory bowel disease.
Potential effects: The potential effects of GW-3965 hydrochloride are vast and varied. Its selectivity as a liver X receptor agonist means that it can target specific areas of the body associated with metabolic disorders, providing greater efficacy and fewer side effects than non-selective treatments. Additionally, its ability to regulate gene expression can help balance cholesterol metabolism and reduce inflammation.
Product mechanism: GW-3965 hydrochloride works by activating liver X receptors, which are transcription factors that regulate the expression of genes involved in lipid metabolism, inflammation, and glucose homeostasis. By targeting these receptors, GW-3965 hydrochloride can promote the clearance of cholesterol from the bloodstream, reduce inflammation, and improve glucose metabolism.
Safety: While GW-3965 hydrochloride has shown significant promise in preclinical studies, its safety profile in humans remains unknown. As with any new medication, it will need to undergo extensive clinical trials to confirm its efficacy and safety before it can be approved for use. It is essential to consult a healthcare professional before starting any new medication or treatment regimen.
Side effects: As a new medication, the potential side effects of GW-3965 hydrochloride are not yet fully understood. However, based on preclinical studies, it appears to have a favorable side effect profile compared to non-selective liver X receptor agonists. Nevertheless, some potential side effects include gastrointestinal distress, headache, fatigue, and muscle weakness.
Dosing information: As GW-3965 hydrochloride is still in the preclinical phase of development, dosing information is not yet available. However, it is likely that dosages will vary depending on the severity of the condition being treated, the patient's age, weight, and other factors. It is crucial to follow the advice of a healthcare professional when taking any medication.
Conclusion: In conclusion, GW-3965 hydrochloride shows significant potential in treating various metabolic disorders such as dyslipidemia, atherosclerosis, and type 2 diabetes. As a selective agonist of liver X receptors, it provides greater efficacy and fewer side effects than non-selective treatments. However, more research is needed to confirm its efficacy and safety before it can be approved for use. It is essential to consult a healthcare professional before starting any new medication or treatment regimen
